Pine Michael Craig 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 14, 2022
Insider Transaction Report
Form 4
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-10+100,000→ 100,000 totalExercise: $12.62Exp: 2032-01-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months